Advertisement

Long-term outcomes of warfarin versus aspirin after Fontan surgery

Published:January 04, 2021DOI:https://doi.org/10.1016/j.jtcvs.2020.12.102

      Abstract

      Objectives

      Because of the nature of the Fontan physiology, patients are at an increased risk of thromboembolic complications. As such, warfarin or aspirin is generally prescribed lifelong for thromboprophylaxis. This study aimed to compare long-term rates of cerebrovascular injury, thrombosis, bleeding, bone mineral density, and quality of life in people living with Fontan circulation receiving warfarin compared with aspirin.

      Methods

      This was a multicenter study of a selected cohort from the Australia and New Zealand Fontan population. Participants underwent cerebral magnetic resonance imaging to detect the presence of cerebrovascular injury (n = 84) and dual-energy X-ray absorptiometry to assess bone mineral density (n = 120). Bleeding (n = 100) and quality of life (n = 90) were assessed using validated questionnaires: Warfarin and Aspirin Bleeding assessment tool and Pediatric Quality of Life Inventory, respectively.

      Results

      Stroke was detected in 33 participants (39%), with only 7 (6%) being clinically symptomatic. There was no association between stroke and Fontan type or thromboprophylaxis type. Microhemorrhage and white matter injury were detected in most participants (96% and 86%, respectively), regardless of thromboprophylaxis type. Bleeding rates were high in both groups; however, bleeding was more frequent in the warfarin group. Bone mineral density was reduced in our cohort compared with the general population; however, this was further attenuated in the warfarin group. Quality of life was similar between the warfarin and aspirin groups. Home international normalized ratio monitoring was associated with better quality of life scores in the warfarin group.

      Conclusions

      Cerebrovascular injury is a frequent occurrence in the Australia and New Zealand Fontan population regardless of thromboprophylaxis type. No benefit of long-term warfarin prophylaxis could be demonstrated over aspirin; however, consideration must be given to important clinical features such as cardiac function and lung function. Furthermore, the association of reduced bone health in children receiving warfarin warrants further mechanistic studies.

      Graphical abstract

      Key Words

      Abbreviations and Acronyms:

      ANZ (Australia and New Zealand), BMD (bone mineral density), CI (confidence interval), DXA (dual-energy X-ray absorptiometry), INR (international normalized ratio), MRI (magnetic resonance imaging), OR (odds ratio), PedsQL (Pediatric Quality of Life Inventory), QoL (quality of life), REDCap (Research Electronic Data Capture), WA-BAT (Warfarin and Aspirin Bleeding assessment tool)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The Journal of Thoracic and Cardiovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rosenthal D.N.
        • Friedman A.H.
        • Kleinman C.S.
        • Kopf G.S.
        • Rosenfeld L.E.
        • Hellenbrand W.E.
        Thromboembolic complications after Fontan operations.
        Circulation. 1995; 92: II287-II293
        • Jahangiri M.
        • Ross D.B.
        • Redington A.N.
        • Lincoln C.
        • Shinebourne E.A.
        Thromboembolism after the Fontan procedure and its modifications.
        Ann Thorac Surg. 1994; 58: 1409-1413
        • Shirai L.K.
        • Rosenthal D.N.
        • Reitz B.A.
        • Robbins R.C.
        • Dubin A.M.
        Arrhythmias and thromboembolic complications after the extracardiac Fontan operation.
        J Thorac Cardiovasc Surg. 1998; 115: 499-505
        • Kaulitz R.
        • Luhmer I.
        • Bergmann F.
        • Rodeck B.
        • Hausdorf G.
        Sequelae after modified Fontan operation: postoperative haemodynamic data and organ function.
        Heart. 1997; 78: 154-159
        • Day R.W.
        • Boyer R.S.
        • Tait V.F.
        • Ruttenberg H.D.
        Factors associated with stroke following the Fontan procedure.
        Pediatr Cardiol. 1995; 16: 270-275
        • du Plessis A.J.
        • Chang A.C.
        • Wessel D.L.
        • Lock J.E.
        • Wernovsky G.
        • Newburger J.W.
        • et al.
        Cerebrovascular accidents following the Fontan operation.
        Pediatr Neurol. 1995; 12: 230-236
        • Mathews K.
        • Bale Jr., J.F.
        • Clark E.B.
        • Marvin Jr., W.J.
        • Doty D.B.
        Cerebral infarction complicating Fontan surgery for cyanotic congenital heart disease.
        Pediatr Cardiol. 1986; 7: 161-166
        • Giglia T.M.
        • Massicotte M.P.
        • Tweddell J.S.
        • Barst R.J.
        • Bauman M.
        • Erickson C.C.
        • et al.
        Prevention and treatment of thrombosis in pediatric and congenital heart disease.
        Circulation. 2013; 128: 2622-2703
        • Tomkiewicz-Pajak L.
        • Hoffman P.
        • Trojnarska O.
        • Lipczynska M.
        • Podolec P.
        • Undas A.
        Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure.
        J Thorac Cardiovasc Surg. 2014; 147: 1284-1290
        • Iyengar A.J.
        • Winlaw D.S.
        • Galati J.C.
        • Gentles T.L.
        • Weintraub R.G.
        • Justo R.N.
        • et al.
        The Australia and New Zealand Fontan registry: description and initial results from the first population-based Fontan registry.
        Intern Med J. 2014; 44: 148-155
        • Beca J.
        • Gunn J.K.
        • Coleman L.
        • Hope A.
        • Reed P.W.
        • Hunt R.W.
        • et al.
        New white matter brain injury after infant heart surgery is associated with diagnostic group and the use of circulatory arrest.
        Circulation. 2013; 127: 971-979
        • Flegal K.
        • Cole T.
        Construction of LMS parameters for the centers for disease control and prevention 2000 growth charts.
        Natl Health Stat Report. 2013; 63: 1-3
        • Rasmussen A.R.
        • Wohlfahrt-Veje C.
        • Tefre de Renzy-Martin K.
        • Hagen C.P.
        • Tinggaard J.
        • Mouritsen A.
        • et al.
        Validity of self-assessment of pubertal maturation.
        Pediatrics. 2015; 135: 86-93
        • Clover E.
        • Miller M.
        • Bannerman E.
        • Magarey A.
        Relative validation of a short food frequency questionnaire to assess calcium intake in older adults.
        Aust N Z J Public Health. 2007; 31: 450-458
        • Attard C.
        • Huang J.
        • Newall F.
        • Monagle P.
        • d'Udekem Y.
        • Ignjatovic V.
        Development and validation of the warfarin-aspirin bleeding assessment tool (WA-BAT) in children.
        J Pediatr Hematol Oncol. 2020; 42: e513-e514
        • Varni J.W.
        • Burwinkle T.M.
        • Seid M.
        The PedsQL™ as a pediatric patient-reported outcome: reliability and validity of the PedsQL™ Measurement Model in 25,000 children.
        Expert Rev Pharmacoecon Outcomes Res. 2005; 5: 705-719
        • Fontan F.
        • Baudet E.
        Surgical repair of tricuspid atresia.
        Thorax. 1971; 26: 240-248
        • Schilling C.
        • Dalziel K.
        • Nunn R.
        • Du Plessis K.
        • Shi W.Y.
        • Celermajer D.
        • et al.
        The Fontan epidemic: population projections from the Australia and New Zealand Fontan registry.
        Int J Cardiol. 2016; 219: 14-19
        • Rychik J.
        • Atz A.M.
        • Celermajer D.S.
        • Deal B.J.
        • Gatzoulis M.A.
        • Gewillig M.H.
        • et al.
        Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association.
        Circulation. 2019; 140: e234-e284
        • Iyengar A.J.
        • Winlaw D.S.
        • Galati J.C.
        • Wheaton G.R.
        • Gentles T.L.
        • Grigg L.E.
        • et al.
        No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients.
        Eur J Cardiothorac Surg. 2016; 50: 980-987
        • Monagle P.
        • Cochrane A.
        • Roberts R.
        • Manlhiot C.
        • Weintraub R.
        • Szechtman B.
        • et al.
        A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children.
        J Am Coll Cardiol. 2011; 58: 645-651
        • McCrindle B.W.
        • Manlhiot C.
        • Cochrane A.
        • Roberts R.
        • Hughes M.
        • Szechtman B.
        • et al.
        Factors associated with thrombotic complications after the Fontan procedure: a secondary analysis of a multicenter, randomized trial of primary thromboprophylaxis for 2 years after the Fontan procedure.
        J Am Coll Cardiol. 2013; 61: 346-353
        • Cordina R.
        • Grieve S.
        • Barnett M.
        • Lagopoulos J.
        • Malitz N.
        • Celermajer D.S.
        Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease.
        Neuroimage Clin. 2014; 4: 319-325
        • Bendaly E.A.
        • DiMeglio L.A.
        • Fadel W.F.
        • Hurwitz R.A.
        Bone density in children with single ventricle physiology.
        Pediatr Cardiol. 2015; 36: 779-785
        • D’Ambrosio P.
        • Tran D.
        • Verrall C.E.
        • Attard C.
        • Singh M.F.
        • Ayer J.
        • et al.
        Prevalence and risk factors for low bone density in adults with a Fontan circulation.
        Congenit Heart Dis. 2019; 14: 987-995
        • Barnes C.
        • Newall F.
        • Ignjatovic V.
        • Wong P.
        • Cameron F.
        • Jones G.
        • et al.
        Reduced bone density in children on long-term warfarin.
        Pediatr Res. 2005; 57: 578-581
        • Lyons R.A.
        • Delahunty A.M.
        • Kraus D.
        • Heaven M.
        • McCabe M.
        • Allen H.
        • et al.
        Children's fractures: a population based study.
        Inj Prev. 1999; 5: 129-132
        • Flynn J.
        • Foley S.
        • Jones G.
        Can BMD assessed by DXA at age 8 predict fracture risk in boys and girls during puberty?: an eight-year prospective study.
        J Bone Miner Res. 2007; 22: 1463-1467
        • Jones S.
        • Newall F.
        • Manias E.
        • Monagle P.
        Assessing outcome measures of oral anticoagulation management in children.
        Thromb Res. 2011; 127: 75-80
        • Uzark K.
        • Zak V.
        • Shrader P.
        • McCrindle B.W.
        • Radojewski E.
        • Varni J.W.
        • et al.
        Assessment of quality of life in young patients with single ventricle after the Fontan operation.
        J Pediatr. 2016; 170: 166-172.e1
        • Uzark K.
        • Jones K.
        • Slusher J.
        • Limbers C.A.
        • Burwinkle T.M.
        • Varni J.W.
        Quality of life in children with heart disease as perceived by children and parents.
        Pediatrics. 2008; 121: e1060-e1067
        • Jaeschke R.
        • Singer J.
        • Guyatt G.H.
        Measurement of health status. Ascertaining the minimal clinically important difference.
        Control Clin Trials. 1989; 10: 407-415
        • Jones S.
        • Monagle P.
        • Manias E.
        • Bruce A.A.
        • Newall F.
        Quality of life assessment in children commencing home INR self-testing.
        Thromb Res. 2013; 132: 37-43
        • Schilling C.
        • Dalziel K.
        • Iyengar A.J.
        • d'Udekem Y.
        The cost differential between warfarin versus aspirin treatment after a Fontan procedure.
        Heart Lung Circ. 2017; 26: e44-e47

      Linked Article

      • Commentary: Less is more
        The Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 4
        • Preview
          While exceedingly common in modern vernacular, the term “less is more” is ascribed to renowned architect Ludwig Mies Van der Rohe. His artistic approach sought to simplify architecture to its most basic elements. By removing ornate details and inefficient uses of space and material, he not only defined an entire architectural movement, but his efficient use of steel and glass also helped to define the modern skyscraper, which persists long after his death.
        • Full-Text
        • PDF
      • Commentary: Aspirin versus warfarin in patients with a Fontan circulation—the clot thickens
        The Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 4
        • Preview
          Thrombotic complications in single-ventricle patients with a Fontan circulation are common. They are likely secondary to a complex interaction of circulating coagulation factor abnormalities, endothelial dysfunction, stasis of blood flow, the presence of prosthetic material and artificial valves, and residual right-to-left shunts. The absence of antithrombotic therapy is associated with an unacceptable incidence of thrombotic complications1 and, therefore, most patients are treated with either aspirin or warfarin.
        • Full-Text
        • PDF
      • Commentary: The case for a comprehensive clinical, basic, and translational research strategy to understand, prevent, detect, and treat cerebrovascular injury in Fontan patients
        The Journal of Thoracic and Cardiovascular SurgeryVol. 162Issue 4
        • Preview
          In this issue of the Journal, the Australian and New-Zealand Fontan Registry Research group compares long-term rates of cerebrovascular injury, thrombosis, bleeding, bone mineral density, and quality of life in Fontan patients receiving warfarin and those receiving aspirin.1 Their take-home messages are (1) asymptomatic cerebrovascular injury is a frequent occurrence in Fontan patients, including stroke (39%), microhemorrhage (96%), and white matter injury (86%); (2) warfarin does not seem to protect against the risk of cerebrovascular injury when compared with aspirin; and (3) warfarin is associated with a greater risk of bleeding and reduced bone mineral density.
        • Full-Text
        • PDF